These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7768562)

  • 21. Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats.
    Touyz RM; Turgeon A; Schiffrin EL
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S300-4. PubMed ID: 11078404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats.
    Yu M; Gopalakrishnan V; McNeill JR
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):845-8. PubMed ID: 10480481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats.
    Vemulapalli S; Watkins RW; Brown A; Cook J; Bernardino V; Chiu PJ
    Life Sci; 1993; 53(10):783-93. PubMed ID: 8355566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
    Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    Li JS; Schürch W; Schiffrin EL
    Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.
    Kowala MC; Murugesan N; Tellew J; Carlson K; Monshizadegan H; Ryan C; Gu Z; Kane B; Fadnis L; Baska RA; Beyer S; Arthur S; Dickinson K; Zhang D; Perrone M; Ferrer P; Giancarli M; Baumann J; Bird E; Panchal B; Yang Y; Trippodo N; Barrish J; Macor JE
    J Pharmacol Exp Ther; 2004 Apr; 309(1):275-84. PubMed ID: 14718594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
    McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
    Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
    Larouche I; Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.
    Ohlstein EH; Douglas SA; Ezekiel M; Gellai M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S321-4. PubMed ID: 7509976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats.
    Tostes RC; Touyz RM; He G; Ammarguellat F; Schiffrin EL
    J Cardiovasc Pharmacol; 2002 Jun; 39(6):892-900. PubMed ID: 12021584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
    Li JS; Schiffrin EL
    Hypertension; 1995 Apr; 25(4 Pt 1):495-500. PubMed ID: 7721389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS; Larivière R; Schiffrin EL
    Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.